Cyclo Therapeutics, Inc. (CYTH)
0.7206
0.00 (0.00%)
Inactive · Last trade price on Mar 26, 2025
Cyclo Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 0.93 | 9.25 | 1.54 | 16.61 | 12.85 | 2.78 |
Cash & Short-Term Investments | 0.93 | 9.25 | 1.54 | 16.61 | 12.85 | 2.78 |
Cash Growth | -48.50% | 499.10% | -90.71% | 29.32% | 361.47% | 25.54% |
Accounts Receivable | 0.19 | 0.12 | 0.05 | 0.49 | 0.07 | 0.14 |
Receivables | 0.19 | 0.12 | 0.05 | 0.54 | 0.11 | 0.18 |
Inventory | 0.24 | 0.25 | 0.25 | 0.23 | 0.24 | 0.24 |
Prepaid Expenses | 0.18 | 2.69 | 2.31 | 2.06 | 0.85 | 0.75 |
Other Current Assets | 1.73 | - | - | - | - | - |
Total Current Assets | 3.26 | 12.32 | 4.16 | 19.44 | 14.05 | 3.96 |
Property, Plant & Equipment | 0.05 | 0.93 | 0.06 | 0.08 | 0.09 | 0.06 |
Long-Term Deferred Charges | 1.95 | - | - | - | - | - |
Total Assets | 5.25 | 13.25 | 4.22 | 19.52 | 14.19 | 4.11 |
Liabilities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Accounts Payable | 5.02 | 4.86 | 2.23 | 3.68 | 3.54 | 3.12 |
Accrued Expenses | 1.25 | 1.68 | 0.97 | - | - | - |
Short-Term Debt | 12.18 | - | - | - | - | - |
Current Portion of Long-Term Debt | - | - | - | 0.13 | 0.11 | - |
Current Portion of Leases | 0.02 | 1.01 | - | 0.02 | 0.02 | 0.02 |
Other Current Liabilities | 0.25 | 0.92 | 0.27 | - | - | - |
Total Current Liabilities | 18.72 | 8.47 | 3.48 | 3.83 | 3.67 | 3.14 |
Long-Term Debt | - | - | - | 0.02 | 0.04 | - |
Long-Term Leases | 0.01 | 0.02 | - | - | 0.02 | 0.04 |
Total Liabilities | 18.73 | 8.49 | 3.48 | 3.85 | 3.74 | 3.18 |
Shareholders' Equity
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 89.54 | 88.61 | 64.53 | 64.02 | 44.51 | 26.06 |
Retained Earnings | -103.01 | -83.86 | -63.8 | -48.35 | -34.06 | -25.12 |
Total Common Equity | -13.47 | 4.76 | 0.73 | 15.67 | 10.45 | 0.94 |
Shareholders' Equity | -13.47 | 4.76 | 0.73 | 15.67 | 10.45 | 0.94 |
Total Liabilities & Equity | 5.25 | 13.25 | 4.22 | 19.52 | 14.19 | 4.11 |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Total Debt | 12.21 | 1.03 | - | 0.17 | 0.19 | 0.05 |
Net Cash (Debt) | -11.28 | 8.21 | 1.54 | 16.44 | 12.65 | 2.73 |
Net Cash Growth | - | 432.16% | -90.61% | 29.96% | 363.23% | 23.17% |
Net Cash Per Share | -0.42 | 0.50 | 0.18 | 2.58 | 7.91 | 2.52 |
Filing Date Shares Outstanding | 28.77 | 28.72 | 10.55 | 8.41 | 6.29 | 1.22 |
Total Common Shares Outstanding | 28.77 | 28.56 | 8.48 | 8.4 | 4.77 | 1.22 |
Working Capital | -15.46 | 3.85 | 0.68 | 15.61 | 10.38 | 0.82 |
Book Value Per Share | -0.47 | 0.17 | 0.09 | 1.86 | 2.19 | 0.77 |
Tangible Book Value | -13.47 | 4.76 | 0.73 | 15.67 | 10.45 | 0.94 |
Tangible Book Value Per Share | -0.47 | 0.17 | 0.09 | 1.86 | 2.19 | 0.77 |
Machinery | - | 0.16 | 0.16 | 0.14 | 0.12 | 0.07 |